ITC To Review Patent Dispute Between Biotech Firms
The U.S. International Trade Commission will weigh in on a patent dispute between biotechnology companies Glycosyn and Jennewein Biotechnologie after announcing Wednesday that it will partially review an administrative law judge's...To view the full article, register now.
Already a subscriber? Click here to view full article